PeerConnect


photo

Deepika Pramod Chopda - Analyst Profile

Research Analyst
Frost & Sullivan
Healthcare

Summary

Authored Comprehensive Life Sciences- Pharmaceuticals and Biotechnology Reports:
Analysis of the European Contract Research Outsourcing Market
Analysis of the European HIV Drugs Market
Analysis of the European Hepatitis B and C Therapeutics Market

Analysis of the European Thrombosis Therapeutics Market
Analysis of the European Multiple Sclerosis Market
Analysis of the Therapeutic Monoclonal Antibodies Market in Europe

Currently Leading a Global Team of Analysts and co-authoring a market report titled " Global Drug Discovery Outsourcing "

Functional Expertise:
Authored Therapeutic market reports featuring comprehensive segments on market forecasts, trends, drivers and restraints, product type segment analysis and geographical description on Germany, France, Italy, Spain, The United Kingdom, Benelux and Scandinavia markets. Contributed insightful articles on the Pharmceutical and Biotechnology Markets for reputed scientific journals, magazines and newsletters across Europe. Identifed and nominated Healthcare Market participants demonstrating excellence in specific market/ product segments and technologies with the Frost & Sullivan "Best Practices" awards. Conducted analyst briefings and interviews on current topics of interest to market participants.


Areas of expertise
MARKET RESEARCH


Recent items from Deepika Pramod Chopda

Published: Nov 27 2013 Best Practices
http://www1.umn.edu/news/features/2013/UR_CONTENT_440332.html...
30 Apr 2013 Blog post
Emerging Combinatorial Therapeutics is the Future Market
This research service gives an in-depth analysis of what lies next for the Hepatitis B and C therapeutics markets. This research service covers, the key trends, drivers, restraints, revenue forecasts and competitive analysis of the Hepatitis B and C therapeutics market along with the respective segments such as interferons, nucleoside analogues for Hepatitis B and SOC, protease inhibitors for Hepatitis C. A comprehensive European Regional analysis (The United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia) and regional policy implications have also been provided.
Published: Feb 18 2013 Market Research
Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth
This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.
Published: Jan 23 2013 Market Research
Opportunities in the Rapidly Changing Clinical Drug Development Outsourcing Market Across Europe
The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical services offered by contract research organisations to pharmaceutical and biotechnology sponsors in conducting clinical trials. The markets analysed in this research service have been approached from a service provider’s point of view. The CRO market has been exclusively segmented based on stages of clinical trials, therapeutic services and geographies.
Published: Sep 05 2012 Market Research
Exploring the Use of Biologics to Control Rising Disease Incidences
The research service aims to analyse and assess the Therapeutic Monoclonal Antibodies market in Europe. This is performed by analysing the key trends and dynamics shaping the industry sector in correlation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and an immense rise in the rate of disease incidences, the use of monoclonal antibodies for therapeutics has been on the increase. The tendency towards biologics has been on the increase during the past decade. This research service provides an in-depth knowledge of the key European markets by presenting significant growth opportunities for the existing drugs and those in the pipeline until 2016.
Published: Jul 05 2012 Market Research
Preventing Inflammation in the Brain and Spinal Cord
The Research Service aims to analyse and assess the European market for Multiple Sclerosis. This is performed by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new healthcare reforms introduced by governments, the Multiple Sclerosis market employs different trends like shift towards biologics which helps the market grow at a fairly steady pace. This research service provides an in-depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over market revenue contributed over a period of time.
Published: Jan 31 2012 Market Research
Un-clotting the clots.
The Research Service aims to analyse and assess the European Thrombosis Therapeutics Market, by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new Healthcare Reforms introduced by the Governments, the Thrombosis market employs different trends to keep the market growing at a fairly steady phase. This study provides an in depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over a period of time.
Published: Dec 27 2011 Market Research

Deepika Pramod 's Tweets

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..